Use of Fluorescence Imaging in Combination with Patent Blue Dye versus Patent Blue Dye Alone in Sentinel Lymph Node Biopsy in Breast Cancer
Authors:
Open Access
- 1 January 2014
- journal article
- Published by XMLink in Journal of Breast Cancer
- Vol. 17 (3) , 250-255
Abstract
Tong M, et al. J Breast Cancer. 2014 Sep;17(3):250-255. http://dx.doi.org/10.4048/jbc.2014.17.3.250Keywords
This publication has 29 references indexed in Scilit:
- Axillary Dissection vs No Axillary Dissection in Women With Invasive Breast Cancer and Sentinel Node MetastasisJAMA, 2011
- Sentinel Node Identification Rate and Nodal Involvement in the EORTC 10981-22023 AMAROS TrialAnnals of Surgical Oncology, 2010
- Complement of peritumoral and subareolar injection in breast cancer sentinel lymph node biopsyJournal of Surgical Oncology, 2009
- Preoperative Lymphoscintigraphy Predicts the Successful Identification but Is Not Necessary in Sentinel Lymph Nodes Biopsy in Breast CancerAnnals of Surgical Oncology, 2007
- Randomized Multicenter Trial of Sentinel Node Biopsy Versus Standard Axillary Treatment in Operable Breast Cancer: The ALMANAC TrialJNCI: Journal of the National Cancer Institute, 2006
- Meta-analysis of sentinel lymph node biopsy after preoperative chemotherapy in patients with breast cancerBritish Journal of Surgery, 2006
- Randomized clinical trial comparing blue dye with combined dye and isotope for sentinel lymph node biopsy in breast cancerBritish Journal of Surgery, 2005
- Evaluation of the Benefit of Using Blue Dye in Addition to Radioisotope for Sentinel Lymph Node Biopsy in Patients With Breast CancerThe Breast Journal, 2005
- Sentinel Node Biopsy Provides More Accurate Staging Than Elective Lymph Node Dissection in Patients With Cutaneous MelanomaAnnals of Surgical Oncology, 2004
- A Trend Analysis of The Relative Value of Blue Dye and Isotope Localization in 2,000 Consecutive Cases of Sentinel Node Biopsy for Breast CancerJournal of the American College of Surgeons, 2001